Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carvedilol versus propranolol for reduction of hepatic venous pressure gradient in cirrhosis with portal hypertension
ChiCTR-IPR-17012836Phase 4Not yet recruiting
- Sponsor
- Nanjing Drum-Tower Hospital
- Start
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in Portal Hypertension (PH) and Cirrhosis comparing Carvedilol arm with Propranolol arm (2 arms). Primary endpoint: Hepatic venous pressure gradient. Planned start Oct 2017; status: not yet recruiting.
02
Drugs
carvedilolpropranolol
03
Conditions
Portal Hypertension (PH)Cirrhosis
Beyond the preview
Go deeper on ChiCTR-IPR-17012836.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17012836.